Bilfinger SE (LON:0NRG)

Market Cap	3.09B
Revenue (ttm)	4.36B
Net Income (ttm)	155.77M
Shares Out	n/a
EPS (ttm)	4.13
PE Ratio	19.82
Forward PE	17.02
Dividend	2.02 (2.18%)
Ex-Dividend Date	May 15, 2025

Volume	1,678
Average Volume	25,578
Open	93.43
Previous Close	92.94
Day's Range	92.05 - 94.35
52-Week Range	42.30 - 97.25
Beta	0.97
RSI	61.46
Earnings Date	Aug 14, 2025

About Revance Therapeutics

Bilfinger SE provides industrial services to customers in the process industry primarily in Europe, North America, and the Middle East. The company offers engineering, project, maintenance, turnaround, rotating equipment, inspection, insulation, scaffolding, corrosion protection, mechanical, electrical, instrumentation, control, and digital services. It also provides new construction and decommissioning of nuclear power plants and treatment of radioactive waste services. In addition, the company offers energy efficiency, carbon capture and stor...

• Industry: Heavy Construction Other Than Building Construction Contractors
• Founded: 1880
• Employees: 31,478
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0NRG

Financial Performance

In 2024, Bilfinger SE's revenue was 5.04 billion, an increase of 12.30% compared to the previous year's 4.49 billion. Earnings were 179.50 million, a decrease of -1.10%.